Society for Thoracic Surgeons Annual Meeting

Fort Lauderdale, Florida
January 28 – February 1, 2012

Focus on Innovation:

Arthroflex^® Offers High Performance Solution for Soft Tissue Repair

LifeNet Health offers a superior acellular bio-implant that leads the market in strength, safety and performance. ArthroFlex^® is an acellular dermal extracellular matrix intended for supplemental support and covering for soft tissue repair. Surgeons prefer ArthroFlex due to:

Strength: Elastin and collagen provide unparalleled strength for supplemental support and covering for soft tissue repair.

Safety: MATRACELL technology removes donor DNA from the dermal matrix, ensuring a biocompatible scaffold to facilitate repair.

Performance: An intact acellular matrix of collagen, elastin and growth factors provides a clean scaffold intended for supplemental support and covering for soft tissue repair.

MATRACELL, a patented and validated process by LifeNet Health, renders the ArthroFlex allograft dermis acellular, without compromising biomechanical or biochemical properties. This process allows the matrix to retain its growth factors, native collagen scaffold, and elastin, which are required for healing. Matracell technology offers the following advantages:

Short processing time reduces the opportunity for water mediated lysis of the natural collagen and elastin scaffold

Utilizes multiple agents to provide for comprehensive tissue disinfection

Does not utilize animal-derived reagents

Uses a validated DNA assessment method, able to detect as little as one nanogram (ng/mL) of nucleic acid to ensure the tissue has been decellularized

Advantages of ArthroFlex™ High Performance Extracellular Matrix

> 97% DNA Removed making ArthroFlex Biocompatible

Intact Acellular Extracellular Matrix allows for product that retains growth factors, elastin and native collagen scaffold

Room Temperature Storage (15° – 30° C) Results in Excellent Handling and Minimal Prep Time

Sterile with 10⁶ SAL (Sterility Assurance Level)